Arkivum Trust for long term data management in pharmaceuticals and life sciences organisations

| May 14, 2019

article image
Make your long term data secure, compliant, accessible and usable for as long as you need it. Secure long term data management for Compliance, IT and Business users in pharmaceuticals, life sciences and healthcare organisations worldwide. Life sciences laboratories are rapidly becoming data enterprises but are your departments reaching their full potential? Do your laboratory managers struggle with consolidating their data sources to optimise long term value and enhance collaboration? Are your IT managers under pressure balancing the need to share and collaborate with data while retaining control and ensuring compliance? Do they struggle with optimising the growing costs of data?

Spotlight

B&S Group.

The B & S Group is a growing and innovative distributor and manufacturer serving the UK pharmaceutical market. We are dedicated to the import, sales, manufacturing and distribution of high quality pharmaceutical and healthcare products.

OTHER ARTICLES

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | April 6, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 6, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | April 6, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Spotlight

B&S Group.

The B & S Group is a growing and innovative distributor and manufacturer serving the UK pharmaceutical market. We are dedicated to the import, sales, manufacturing and distribution of high quality pharmaceutical and healthcare products.

Events